Clinical trial
Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of…
NCT00209807 · Hospital Universitari Vall d'Hebron Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00209807 |
|---|---|
| Title | Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder |
| Official title | Effect of Escitalopram vs. Reboxetine on Somatic and Visceral Sensitivity of Patients With Major Depressive Disorder: a Randomized, Double Blind Clinical Trial |
| Lead sponsor | Hospital Universitari Vall d'Hebron Research Institute, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depression, Pain, Abdominal Pain |
| Intervention type | Drug, Other |
| Interventions | escitalopram, Reboxetine, No intervention |
| Enrollment | 42 |
| Start date | Sep 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Apr 1, 2011 |
| First posted | Sep 21, 2005 |
| Last update posted | May 27, 2010 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: